|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 471/18 | (2006.01) |
| A61K 31/4162 | (2006.01) | ||
| A61P 7/02 | (2006.01) |
| (11) | Patento numeris | 3089979 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15747721.7 |
| Europos patento paraiškos padavimo data | 2015-07-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data | 2017-12-27 |
| (86) | Numeris | PCT/US2015/042576 |
| Data | 2015-07-29 |
| (87) | Numeris | WO 2016/053455 |
| Data | 2016-04-07 |
| (30) | Numeris | Data | Šalis |
| 201462058316 P | 2014-10-01 | US |
| (72) |
DILGER, Andrew K., US
CORTE, James R., US
DE LUCCA, Indawati, US
FANG, Tianan, US
YANG, Wu, US
WANG, Yufeng, US
PABBISETTY, Kumar Balashanmuga, US
EWING, William R., US
ZHU, Yeheng, US
WEXLER, Ruth R., US
PINTO, Donald J.P., US
ORWAT, Michael J., US
SMITH II, Leon M., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirimidinonai, kaip faktoriaus XIa inhibitoriai |
| PYRIMIDINONES AS FACTOR XIA INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-06-19 | 11 | 289.00 EUR |
| 2026-07-29 |